Sabine Breukers

In April 2020, I joined the group of Lotje Zuur as a MD, PhD-student.

My project focuses on the efficacy and safety of neoadjuvant anti-PD1 with or without anti-CTLA4 in (advanced) Cutaneous Squamous Cell Carcinoma. Furthermore, identify clinical and translational biomarkers for response predictions.